Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

NEOGENOMICS INC Director's Dealing 2021

Dec 31, 2021

32227_dirs_2021-12-30_e578976f-c2a8-4213-9dcc-0eaac6cc7e8c.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NEOGENOMICS INC (NEO)
CIK: 0001077183
Period of Report: 2021-12-30

Reporting Person: BALLIET JENNIFER (VP and Chief Culture Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-12-30 Common Stock A 21400 Acquired 48615 Direct

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Stock Option (Right to Buy) $7.52 2022-04-28 Common Stock (7000.0) 7000 Direct
Stock Option (Right to Buy) $8.03 2023-02-26 Common Stock (33334.0) 33334 Direct
Stock Option (Right to Buy) $19.6 2024-03-01 Common Stock (17496.0) 17496 Direct
Stock Option (Right to Buy) $28.33 2027-03-02 Common Stock (15006.0) 15006 Direct
Stock Option (Right to Buy) $53.17 2028-03-02 Common Stock (10551.0) 10551 Direct
Stock Option (Right to Buy) $43.95 2028-07-05 Common Stock (4050.0) 4050 Direct

Footnotes

F1: On December 30, 2021, Ms. Balliet was granted 21,400 restricted stock awards. These awards vest ratably over three years with the first tranche vesting on December 31, 2022.

F2: On April 28, 2017, Ms. Balliet was granted 60,000 stock options. These options vested ratably over the first three anniversaries of the grant date.

F3: On February 26, 2018, Ms. Balliet was granted 72,500 stock options. These options vested ratably over the first three anniversary dates of the grant date.

F4: On March 1, 2019, Ms. Balliet was granted 17,496 stock options. These options vest ratably over the first four anniversary dates of the grant date.

F5: On March 2, 2020, Ms. Balliet was granted 15,006 stock options. These options vest ratably over the first four anniversary dates of the grant date.

F6: On March 2, 2021, Ms. Balliet was granted 10,551 stock options. These options vest ratably over the first four anniversary dates of the grant date.

F7: On July 5, 2021, Ms. Balliet was granted 4,050 stock options. These options vest ratably over the first four anniversary dates of the grant date.